Literature DB >> 35876704

Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV.

Jack T Stapleton1,2, Roger J Bedimo3,4, Giovanni Guaraldi5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35876704      PMCID： PMC9326846          DOI： 10.1097/QAD.0000000000003285

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.632


× No keyword cloud information.
  9 in total

1.  Association of tenofovir exposure with kidney disease risk in HIV infection.

Authors:  Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

Review 2.  Dyslipidemia and lipid management in HIV-infected patients.

Authors:  Janet Lo
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-04       Impact factor: 3.243

3.  Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; M Pang; W Doerrler; J K Shigenaga; P Jensen; K R Feingold
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

4.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Michael S Saag; Rajesh T Gandhi; Jennifer F Hoy; Raphael J Landovitz; Melanie A Thompson; Paul E Sax; Davey M Smith; Constance A Benson; Susan P Buchbinder; Carlos Del Rio; Joseph J Eron; Gerd Fätkenheuer; Huldrych F Günthard; Jean-Michel Molina; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

5.  Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials.

Authors:  Victoria Pilkington; Sophie L Hughes; Toby Pepperrell; Kaitlyn McCann; Dzintars Gotham; Anton L Pozniak; Andrew Hill
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.177

6.  Lipid abnormalities in a never-treated HIV-1 subtype C-infected African population.

Authors:  Carla Maria T Fourie; Johannes M Van Rooyen; Annamarie Kruger; Aletta E Schutte
Journal:  Lipids       Date:  2009-11-15       Impact factor: 1.880

7.  Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Authors:  C Grunfeld; D P Kotler; J K Shigenaga; W Doerrler; A Tierney; J Wang; R N Pierson; K R Feingold
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965

8.  Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV.

Authors:  Cecile D Lahiri; Yanxun Xu; Kunbo Wang; Jessica A Alvarez; Anandi N Sheth; Jane O'Halloran; Amanda B Spence; Phyllis Tien; Deborah R Gustafson; Joel Milam; Margaret A Fischl; Deborah Konkle-Parker; Adaora A Adimora; Anjali Sharma; Kathleen M Weber; Igho Ofotokun; Leah H Rubin
Journal:  AIDS Res Hum Retroviruses       Date:  2021-01-12       Impact factor: 1.723

9.  Incident bone fracture and mortality in a large HIV cohort outpatient study, 2000-2017, USA.

Authors:  Linda Battalora; Carl Armon; Frank Palella; Jun Li; Edgar T Overton; John Hammer; Jack Fuhrer; Richard M Novak; Kimberly Carlson; John R Spear; Kate Buchacz
Journal:  Arch Osteoporos       Date:  2021-08-02       Impact factor: 2.617
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.